MOTIVATION: A current challenge in understanding cancer processes is to pinpoint which mutations influence the onset and progression of disease. Toward this goal, we describe a method called PARADIGM-SHIFT that can predict whether a mutational event is neutral, gain-or loss-of-function in a tumor sample. The method uses a belief-propagation algorithm to infer gene activity from gene expression and copy number data in the context of a set of pathway interactions. RESULTS: The method was found to be both sensitive and specific on a set of positive and negative controls for multiple cancers for which pathway information was available. Application to the Cancer Genome Atlas glioblastoma, ovarian and lung squamous cancer datasets revealed severa...
Recent advances in collecting sequencing data from tumors is promising for both immediate individual...
Cancer is mainly caused by somatic genome alterations (SGAs). Precision oncology involves identifyin...
Cancers are characterized by somatic mutation arising from the interplay of mutagen exposure and def...
MOTIVATION: A current challenge in understanding cancer processes is to pinpoint which mutations inf...
Since response to therapy can differ greatly between cancer patients, a precision medicine approach ...
Identifying key somatic alterations in cancer is a critical step in understanding the mechanisms tha...
Cancer is a complex disease driven by somatic genomic alterations (SGAs) that perturb signaling path...
Cancer occurs via an accumulation of somatic genomic alterations in a process of clonal evolution. T...
Mutations in 15 cancers, sourced from the COSMIC Whole Genomes database, and 297 human pathways, arr...
Mutations are the driving force of evolution, yet they underlie many diseases and, in particular, ca...
Cancer is an umbrella terminology that binds hundreds of complex genetic diseases based on a set of ...
The genome of a cancer cell is replete with somatic mutations imprinted by the activities of differe...
Motivation: The expansion of cancer genome sequencing continues to stimulate development of analytic...
Cancer research, like many areas of science, is adapting to a new era characterized by increasing qu...
Identifying driver mutation is important in understanding disease mechanism and future application o...
Recent advances in collecting sequencing data from tumors is promising for both immediate individual...
Cancer is mainly caused by somatic genome alterations (SGAs). Precision oncology involves identifyin...
Cancers are characterized by somatic mutation arising from the interplay of mutagen exposure and def...
MOTIVATION: A current challenge in understanding cancer processes is to pinpoint which mutations inf...
Since response to therapy can differ greatly between cancer patients, a precision medicine approach ...
Identifying key somatic alterations in cancer is a critical step in understanding the mechanisms tha...
Cancer is a complex disease driven by somatic genomic alterations (SGAs) that perturb signaling path...
Cancer occurs via an accumulation of somatic genomic alterations in a process of clonal evolution. T...
Mutations in 15 cancers, sourced from the COSMIC Whole Genomes database, and 297 human pathways, arr...
Mutations are the driving force of evolution, yet they underlie many diseases and, in particular, ca...
Cancer is an umbrella terminology that binds hundreds of complex genetic diseases based on a set of ...
The genome of a cancer cell is replete with somatic mutations imprinted by the activities of differe...
Motivation: The expansion of cancer genome sequencing continues to stimulate development of analytic...
Cancer research, like many areas of science, is adapting to a new era characterized by increasing qu...
Identifying driver mutation is important in understanding disease mechanism and future application o...
Recent advances in collecting sequencing data from tumors is promising for both immediate individual...
Cancer is mainly caused by somatic genome alterations (SGAs). Precision oncology involves identifyin...
Cancers are characterized by somatic mutation arising from the interplay of mutagen exposure and def...